Bank of New York Mellon Corp - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260508. A total of 17 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2019$40,000
+5.3%
16,644
-3.6%
0.00%
Q4 2018$38,00017,2690.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2019
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 16,670$23,0000.00%
A.R.T. Advisors, LLC 30,940$42,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,090$1,0000.00%
UBS Group AG 8,402$12,0000.00%
NEXT Financial Group, Inc 43$00.00%
DIMENSIONAL FUND ADVISORS LP 10,443$14,0000.00%
BANK OF AMERICA CORP /DE/ 7$00.00%
WELLS FARGO & COMPANY/MN 300$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 16,399$22,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders